BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10372934)

  • 21. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
    Dehghani SM; Erjaee A; Imanieh MH; Haghighat M
    Dig Dis Sci; 2009 Aug; 54(8):1720-4. PubMed ID: 19005755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori.
    Spinzi G; Bortoli A; Colombo E; Lesinigo E; Venturelli R; Terruzzi V; Imperiali G; Minoli G
    Aliment Pharmacol Ther; 1997 Apr; 11(2):317-22. PubMed ID: 9146769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
    Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J
    Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
    Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
    World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
    Chen S; Chen Z; Bei L
    Zhonghua Nei Ke Za Zhi; 1996 Dec; 35(12):799-802. PubMed ID: 9592303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
    Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan.
    Habu Y; Mizuno S; Hirano S; Kiyota K; Inokuchi H; Kimoto K; Nakajima M; Kawai K
    Digestion; 1998; 59(4):321-5. PubMed ID: 9693202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
    Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
    Huang WH; Ho AS; Shyu RY; Lee SC; Lee MM; Hsu CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):448-55. PubMed ID: 9745160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.
    Georgopoulos SD; Ladas SD; Karatapanis S; Triantafyllou K; Spiliadi C; Mentis A; Artikis V; Raptis SA
    Aliment Pharmacol Ther; 2002 Mar; 16(3):569-75. PubMed ID: 11876712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
    Bayerdörffer E; Lind T; Díte P; Bardhan KD; O'Morain C; Delchier JC; Spiller R; Veldhuyzen van Zanten S; Sipponen P; Mégraud F; Zeijlon L
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S19-22; discussion S23-4. PubMed ID: 10503818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
    Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
    Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic options after failed Helicobacter pylori eradication therapy.
    van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
    Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori.
    Chu KM; Choi HK; Tuen HH; Law SY; Branicki FJ; Wong J
    Am J Gastroenterol; 1998 Sep; 93(9):1436-42. PubMed ID: 9732921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
    Goh K; Parasakthi N; Cheah P; Ranjeev C; Rosmawati M; Tan Y; Chin S
    J Gastroenterol Hepatol; 2000 Aug; 15(8):910-4. PubMed ID: 11022833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori.
    Katelaris PH; Patchett SE; Zhang ZW; Domizio P; Farthing MJ
    Aliment Pharmacol Ther; 1995 Apr; 9(2):205-8. PubMed ID: 7605864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.
    Bazzoli F; Zagari M; Pozzato P; Varoli O; Fossi S; Ricciardiello L; Alampi G; Nicolini G; Sottili S; Simoni P; Roda A; Roda E
    Aliment Pharmacol Ther; 1998 May; 12(5):439-45. PubMed ID: 9663723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
    Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
    Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
    Bilardi C; Dulbecco P; Zentilin P; Reglioni S; Iiritano E; Parodi A; Accornero L; Savarino E; Mansi C; Mamone M; Vigneri S; Savarino V
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):997-1002. PubMed ID: 15551252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.